High Impact Training to Patients with Prostate Cancer and Bone Metastases
Recruiting
N/A
Interventional Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 102 (estimated)
- Sponsor
- Copenhagen University Hospital at Herlev · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
HIP is a randomized controlled trial. The aim is investigate the effect, safety and feasibility of brief, high-impact exercise targeting bones in patients with prostate cancer and bone metastases. Furthermore, to investigate the effects of the intervention on bone status (bone mineral density) and body composition, physical function and performance, patient reported quality-of-life outcomes, falls…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with metastatic hormone sensitive prostate cancer (mHSPC)
* Patients must have bone metastases according to the most recent imaging (Bone scan, CT, MRI and/or PET)
* Patients must be treated with androgen deprivation therapy (ADT) (orchiectomy, luteinizing hormone-rel…
Contacts